MA25347A1 - Composition du lypoglycan et methodes de traitement des infections d'origines parasites. - Google Patents

Composition du lypoglycan et methodes de traitement des infections d'origines parasites.

Info

Publication number
MA25347A1
MA25347A1 MA26327A MA26327A MA25347A1 MA 25347 A1 MA25347 A1 MA 25347A1 MA 26327 A MA26327 A MA 26327A MA 26327 A MA26327 A MA 26327A MA 25347 A1 MA25347 A1 MA 25347A1
Authority
MA
Morocco
Prior art keywords
composition
lypoglycan
methods
treating infections
origins
Prior art date
Application number
MA26327A
Other languages
English (en)
Inventor
H Semprevivo Lioyd
Original Assignee
Univ Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Massachusetts filed Critical Univ Massachusetts
Publication of MA25347A1 publication Critical patent/MA25347A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
MA26327A 1999-03-12 2001-09-12 Composition du lypoglycan et methodes de traitement des infections d'origines parasites. MA25347A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12393199P 1999-03-12 1999-03-12

Publications (1)

Publication Number Publication Date
MA25347A1 true MA25347A1 (fr) 2001-12-31

Family

ID=22411778

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26327A MA25347A1 (fr) 1999-03-12 2001-09-12 Composition du lypoglycan et methodes de traitement des infections d'origines parasites.

Country Status (17)

Country Link
US (3) US6428793B1 (fr)
EP (1) EP1175226B1 (fr)
JP (1) JP2002538220A (fr)
AT (1) ATE439857T1 (fr)
AU (1) AU771373B2 (fr)
BR (1) BR0008949A (fr)
CA (1) CA2364507A1 (fr)
DE (1) DE60042776D1 (fr)
HU (1) HUP0200466A3 (fr)
MA (1) MA25347A1 (fr)
MX (1) MXPA01009206A (fr)
NO (1) NO20014411L (fr)
NZ (1) NZ514112A (fr)
PL (1) PL203789B1 (fr)
TR (3) TR200202078T2 (fr)
WO (1) WO2000053220A1 (fr)
ZA (1) ZA200107502B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US7164520B2 (en) 2004-05-12 2007-01-16 Idc, Llc Packaging for an interferometric modulator
WO2006041613A2 (fr) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticules destinees au traitement de cellules hepatomes
BR112012009500A2 (pt) * 2009-10-21 2016-11-29 Eth Zuerich utilidade médica de proteínas de ligação de glicano e glicanos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598147B1 (fr) * 1986-04-30 1988-08-26 Pasteur Institut Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene.
FR2601021B2 (fr) * 1986-07-07 1988-11-18 Pasteur Institut Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
US5280113A (en) * 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5212298A (en) 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5679347A (en) * 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US5541075A (en) * 1993-02-05 1996-07-30 Heska Corporation Carbohydrate-based vaccine and diagnostic reagent for trichinosis
BR9305075A (pt) * 1993-12-16 1995-08-08 Fundacao Oswaldo Cruz Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
AU5928999A (en) * 1998-09-21 2000-04-10 Richard D. Cummings Assays for helminth infections

Also Published As

Publication number Publication date
DE60042776D1 (de) 2009-10-01
EP1175226A4 (fr) 2005-01-05
PL350989A1 (en) 2003-02-24
BR0008949A (pt) 2002-09-24
AU771373B2 (en) 2004-03-18
HUP0200466A3 (en) 2006-11-28
JP2002538220A (ja) 2002-11-12
US7204983B2 (en) 2007-04-17
NO20014411L (no) 2001-11-09
US20060228382A1 (en) 2006-10-12
US7063848B2 (en) 2006-06-20
NO20014411D0 (no) 2001-09-11
ATE439857T1 (de) 2009-09-15
EP1175226A1 (fr) 2002-01-30
TR200103231T2 (tr) 2002-03-21
MXPA01009206A (es) 2003-07-14
CA2364507A1 (fr) 2000-09-14
HUP0200466A2 (en) 2002-06-29
TR200202078T2 (tr) 2002-11-21
US6428793B1 (en) 2002-08-06
EP1175226B1 (fr) 2009-08-19
US20020160021A1 (en) 2002-10-31
NZ514112A (en) 2003-08-29
PL203789B1 (pl) 2009-11-30
AU3625100A (en) 2000-09-28
WO2000053220A1 (fr) 2000-09-14
TR200202066T2 (tr) 2004-12-21
ZA200107502B (en) 2003-02-26

Similar Documents

Publication Publication Date Title
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
ATE195740T1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
GR3032037T3 (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
DK0778775T3 (da) Parenteral tirilazad-præparat med coopløsningsmiddel
DE69304521D1 (de) Impfstoff Adjuvans
PT1221968E (pt) Processo de obtenção de respostas imunes celulares de proteínas
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
BR9507400A (pt) Composições imunogénicas de polissacaridio streptococal grupo a e processos
ATE124265T1 (de) Idiotypen-impfung gegen b-zell-lymphoma.
PT692028E (pt) Farmacos baseados em papilomavirus
AU5673399A (en) Compositions and methods for treating intracellular infections
ES2188788T3 (es) Bi-heteroarilmetoxifenilalquil carboxilatos simetricos que inhiben la biosintesis de leucotrieno.
KR890701099A (ko) 기침 및 기관지 협착을 치료하기 위한 5-ht3 수용기 길항물질
BR9806971A (pt) Epìtopes de célula t universal para vacinas anti-malária.
NO20023102L (no) Fremgangsmåte og formulering for behandling av residens mot anti-hypertensiver og relaterte tilstander
EP1037918A4 (fr) Procede et composition pour ameliorer l'efficacite d'un vaccin
NO20014411D0 (no) Lipoglykan-blandinger og metoder for behandling av parasitt- infeksjoner
DE60045516D1 (de) Pflanzen lektine als mukosale adjuvantien
FR2735984B1 (fr) Vaccin contre des agents infectieux ayant une phase intracellulaire, composition pour le traitement et la prevention des infections a hiv, anticorps et procede de diagnostic
FR2457102A1 (fr) Composition therapeutique a base de sulfamide et d'extrait titre de centella asiatica destinee notamment au traitement des infections a chlamydiae
EP0328460A3 (fr) 1-(4-aminophényl)-2-hexaméthylèneiminopropanone, procédé de préparation et utilisation en thérapeutique
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
AR025308A1 (es) Composiciones y metodos para tratar condiciones alergicas e inflamatorias con tos.
SE9704451D0 (sv) New method and compositions for the treatment of autoimmune diseases